Transplantation for Hepatocellular Carcinoma

Angela Hill; Franklin Olumba; William Chapman

doi:10.1016/j.suc.2023.09.002

Transplantation for Hepatocellular Carcinoma

Surg Clin North Am. 2024 Feb;104(1):103-111. doi: 10.1016/j.suc.2023.09.002. Epub 2023 Oct 11.

Authors

Angela Hill¹, Franklin Olumba¹, William Chapman²

Affiliations

¹ Division of General Surgery, Washington University School of Medicine, MSC 8109-05-06, 660 South Euclid Avenue, St Louis, MO 63110, USA.
² Division of General Surgery, Washington University School of Medicine, Section of Transplantation, MSC 8109-05-06, 660 South Euclid Avenue, St Louis, MO 63110, USA. Electronic address: chapmanw@wustl.edu.

PMID: 37953029
DOI: 10.1016/j.suc.2023.09.002

Abstract

Liver transplantation is the only curative treatment of many patients with HCC. To be successful, patients must undergo careful multidisciplinary evaluation and neoadjuvant treatment for bridging or downstaging. Patients with stable disease for 6 months are listed for transplant, after which regular surveillance is required to detect recurrence.

Keywords: HCC; Hepatocellular carcinoma; Liver cancer; Liver transplant; Transplantation.

Publication types

Review

MeSH terms

Carcinoma, Hepatocellular* / diagnosis
Humans
Liver Neoplasms* / diagnosis
Liver Transplantation*
Neoplasm Recurrence, Local / pathology
Neoplasm Staging
Treatment Outcome